Related references
Note: Only part of the references are listed.CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with Stroke
Giovanni Davì et al.
Journal of Atherosclerosis and Thrombosis (2011)
Thromboxane A2 promotes soluble CD40 ligand release from human platelets
Yukiko Enomoto et al.
ATHEROSCLEROSIS (2010)
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis
Dirk Lievens et al.
BLOOD (2010)
Soluble CD40 Ligand Impairs the Function of Peripheral Blood Angiogenic Outgrowth Cells and Increases Neointimal Formation After Arterial Injury
Mihail Hristov et al.
CIRCULATION (2010)
Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions
Silvia Riondino et al.
CLINICAL BIOCHEMISTRY (2010)
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
Esther Lutgens et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
CD40L induces inflammation and adipogenesis in adipose cells - a potential link between metabolic and cardiovascular disease
Anna Missiou et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Soluble CD40 Ligand Levels in Essential Hypertensive Men: Evidence of a Possible Role of Insulin Resistance
Giuseppe Penno et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention
Slobodan D. Obradovic et al.
BLOOD COAGULATION & FIBRINOLYSIS (2009)
Preoperative sCD40L Levels Predict Risk of Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft Surgery
Charalambos Antoniades et al.
CIRCULATION (2009)
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study
Joanna J. Wykrzykowska et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)
Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets
Stephan Reinboldt et al.
PLATELETS (2009)
The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling
Marjo M. P. C. Donners et al.
BLOOD (2008)
Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation - Relationship to soluble P-selectin, stroke risk factors, and risk factor intervention
Anirban Choudhury et al.
CHEST (2008)
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18
David A. Morrow et al.
EUROPEAN HEART JOURNAL (2008)
Soluble CD40 ligand and atrial fibrillation: Relationship to platelet activation, and endothelial damage/dysfunction
A. D. Blann et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity
I. Chung et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Increased platelet activation markers in rheumatoid arthritis: Are they related with subclinical atherosclerosis?
Guelsuem Emel Pamuk et al.
PLATELETS (2008)
Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16
Benjamin A. Olenchock et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2008)
Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography
Matthew T. Rondina et al.
CARDIOLOGY (2008)
Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation
Domenico Ferro et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes
D. Tousoulis et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Increased plasma concentrations of soluble CD40 ligand in acute coronary syndrome depend on in vitro platelet activation
Boris T. Ivandic et al.
CLINICAL CHEMISTRY (2007)
TRAF-1,-2,-3,-5, and-6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells
Andreas Zirlik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome
Fred S. Apple et al.
CLINICAL CHEMISTRY (2007)
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1
Andreas Zirlik et al.
CIRCULATION (2007)
Influence of sample type on soluble CD40 ligand assessment in patients with acute coronary syndromes
Michael Weber et al.
THROMBOSIS RESEARCH (2007)
Influence of pre-analytical and analytical factors on soluble CD40L measurements
Nerea Varo et al.
CLINICAL SCIENCE (2006)
T cells in atherogenesis - For better or for worse?
Anna-Karin L. Robertson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes
Euler R. F. Mantenti et al.
CLINICAL CARDIOLOGY (2006)
Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome
Anders Malarstig et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Internalization of CD40 regulates its signal transduction in vascular endothelial cells
Yali Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Differential regulation of soluble and membrane CD40L proteins in T cells
Kelli M. G. Matthies et al.
CELLULAR IMMUNOLOGY (2006)
CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease
D Tanne et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Leukocyte CD40L deficiency affects the CD25+ CD4 T cell population but does not affect atherosclerosis
MLF Smook et al.
ATHEROSCLEROSIS (2005)
Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease
PJ Mason et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
CD40 ligand influences platelet release of reactive oxygen intermediates
S Chakrabarti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
The relationship between soluble CD40 ligand levels and Framingham coronary heart disease risk score in healthy volunteers
S Verma et al.
ATHEROSCLEROSIS (2005)
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis
S Novo et al.
STROKE (2005)
Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers
SA Harding et al.
CIRCULATION (2004)
CD154/CD40-mediated expression of CD154 in endothelial cells:: Consequences for endothelial cell-monocyte interaction
AH Wagner et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study
S Kinlay et al.
CIRCULATION (2004)
Differences of soluble CD40L in sera and plasma: Implications on CD40L assay as a marker of thrombotic risk
ER Ahn et al.
THROMBOSIS RESEARCH (2004)
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization
MI Furman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques
A Aggarwal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus - Relationships to cardiovascular disease and risk factor intervention
HS Lim et al.
CIRCULATION (2004)
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty
F Cipollone et al.
CIRCULATION (2003)
Soluble CD40 ligand induces β3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling
KSS Prasad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Soluble CD40L -: Risk prediction after acute coronary syndromes
N Varo et al.
CIRCULATION (2003)
TNF-receptor-associated factors as targets for drug development
JM Zapata
EXPERT OPINION ON THERAPEUTIC TARGETS (2003)
CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation
DP Inwald et al.
CIRCULATION RESEARCH (2003)
CD154 (CD40 ligand)-deficient mice exhibit prolonged bleeding time and decreased shear-induced platelet aggregates
AR Crow et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Soluble CD40 ligand in acute coronary syndromes
C Heeschen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation
L Nannizzi-Alaimo et al.
CIRCULATION (2003)
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells
U Schönbeck et al.
CIRCULATION (2002)
Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling
JR Arron et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia effects of statin therapy
F Cipollone et al.
CIRCULATION (2002)
Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor κB, and Egr-1
U Bavendiek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CD40L stabilizes arterial thrombi by a beta(3) integrin-dependent mechanism
P Andre et al.
NATURE MEDICINE (2002)
CD40 signaling and plaque instability
U Schönbeck et al.
CIRCULATION RESEARCH (2001)
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
CD Garlichs et al.
HEART (2001)
Soluble CD40L and cardiovascular risk in women
U Schönbeck et al.
CIRCULATION (2001)
The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40
V Henn et al.
BLOOD (2001)
Platelet CD40 ligand (CD40L) -: subcellular localization, regulation of expression, and inhibition by clopidogrel
A Hermann et al.
PLATELETS (2001)
The CD40/CD154 receptor/ligand dyad
U Schonbeck et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
E Lutgens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
T Kawai et al.
NATURE MEDICINE (2000)
Share Paper
